NCT04163718 2026-01-06
TGR-1202 (Umbralisib) in Treatment Naïve Patients With Chronic Lymphocytic Leukemia (CLL)
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated
H. Lee Moffitt Cancer Center and Research Institute
TG Therapeutics, Inc.
TG Therapeutics, Inc.
TG Therapeutics, Inc.
University of Alabama at Birmingham
TG Therapeutics, Inc.
TG Therapeutics, Inc.
TG Therapeutics, Inc.
Weill Medical College of Cornell University
University of Washington
Columbia University
Columbia University